Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.
Every year 12th of November is a global event and is marked as World Pneumonia Day. The day first gained identity in 2009 by WHO and UNICEF for the purpose of ‘stop pneumonia’. On this day, several seminars around the world are conducted and campaigns are designed in localities, by hospitals and healthcare sectors to educate people and create awareness […]
Mono, or infectious mononucleosis, is a contagious illness usually caused by the Epstein-Barr virus (EBV). The virus spreads easily through bodily fluids like saliva, which is the reason why mono is sometimes referred to as “kissing disease.” Overview of Mono (Copyright photo from https://www.everydayhealth.com/mononucleosis/symptoms/) In line with the trusted source , mono occurs most often in people ages 15 to 17, […]
In contrary to the traditional testing usually conducted in laboratories, point-of-care testing (POCT) refers to the medical diagnostic testing done near the point of care. POCT enables the decentralization of some of the diagnostic tests while bringing the testing and the diagnoses closer to the patient. The prompt availability of the results makes healthcare professionals reach immediate and informed decisions […]
Seasonal influenza has finally arrived during the fall and will peak between December and February. Together with the ongoing battle with COVID-19, these two viruses can pose an even greater threat to communities worldwide. Influenza (Flu) and COVID-19 are both contagious respiratory illnesses, yet caused by different viruses. Because some of the symptoms of flu and COVID-19 are similar, it […]
Cervical cancer is the fourth most frequent cancer among women worldwide, with about 604,000 new cases and 342,000 deaths in 2020. Nearly 90% of the new cases and deaths globally in 2020 occurred in low-income and middle-income countries.1 Most HPV infections don’t cause cancer, but high-risk infections that persist can cause cancer. Especially for types 16 and 18, they are […]